U.S. Markets close in 5 hrs 32 mins
  • S&P 500

    4,245.93
    -9.22 (-0.22%)
     
  • Dow 30

    34,258.61
    -135.14 (-0.39%)
     
  • Nasdaq

    14,099.38
    -74.76 (-0.53%)
     
  • Russell 2000

    2,318.27
    -7.88 (-0.34%)
     
  • Crude Oil

    71.83
    +0.95 (+1.34%)
     
  • Gold

    1,862.00
    -3.90 (-0.21%)
     
  • Silver

    27.68
    -0.36 (-1.28%)
     
  • EUR/USD

    1.2129
    +0.0006 (+0.0485%)
     
  • 10-Yr Bond

    1.5060
    +0.0050 (+0.33%)
     
  • Vix

    16.95
    +0.56 (+3.42%)
     
  • GBP/USD

    1.4078
    -0.0030 (-0.2098%)
     
  • USD/JPY

    110.1190
    +0.0580 (+0.0527%)
     
  • BTC-USD

    39,994.10
    -897.00 (-2.19%)
     
  • CMC Crypto 200

    996.49
    -14.11 (-1.40%)
     
  • FTSE 100

    7,175.09
    +28.41 (+0.40%)
     
  • Nikkei 225

    29,441.30
    +279.50 (+0.96%)
     

This IPO Stock Is Staring Down A Buy Point; Will Vaccines Drive It There?

·2 min read
This IPO Stock Is Staring Down A Buy Point; Will Vaccines Drive It There?
  • Oops!
    Something went wrong.
    Please try again later.

Late Monday, Maravai reported adjusted income of 26 cents per share on $148.21 million in sales. But the fresh IPO stock was unmoved in after-hours trading.